Investigation of Ifosfamide Toxicity Induces Common Upstream Regulator in Liver and Kidney

Hyoung-Yun Han1,2, Mi-Sun Choi1,3, Seokjoo Yoon1,2

  • 1Department of Predictive Toxicology, Korea Institute of Toxicology, 141 Gajeong-ro, Yuseong-gu, Daejeon 34114, Korea.

Insights

Ifosfamide causes severe kidney toxicity in rats after repeated doses, affecting cholesterol and kidney failure genes. Interferon regulatory factor 7 is a key regulator identified in liver and kidney tissues.

Area of Science:

  • Toxicology
  • Pharmacology
  • Genomics

Background:

  • Ifosfamide is a chemotherapy drug used for solid cancers.
  • Understanding its toxicity is crucial for patient safety.

Purpose of the Study:

  • To evaluate the toxicity of ifosfamide in rats.
  • To identify molecular mechanisms of ifosfamide-induced toxicity using toxicogenomics.

Main Methods:

  • Single and multiple dose intraperitoneal administration of ifosfamide in rats.
  • Good Laboratory Practice (GLP) guidelines.
  • Microarray analysis and real-time RT-PCR.

Main Results:

  • Single ifosfamide dose (50 mg/kg) showed no toxicity.
  • Repeated doses caused severe renal toxicity, with elevated blood urea nitrogen and creatinine.
  • Gene expression analysis revealed affected cholesterol synthesis genes in the liver and renal failure genes in the kidney.
  • Interferon regulatory factor 7 was identified as a key upstream regulator in both organs.

Conclusions:

  • Ifosfamide exhibits kidney-biased toxicity.
  • Identical gene expression alterations were observed in the liver and kidney.
  • Further toxicogenomic studies are needed to clarify gene-toxicity relationships.

Related Concept Videos

Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.7K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
19
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Hepatic Drug Excretion: Influencing Factors01:16

Hepatic Drug Excretion: Influencing Factors

The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
266
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.6K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
15.3K